Injectable Drug Delivery

Document Sample
Injectable Drug Delivery Powered By Docstoc
					Injectable Drug Delivery
Market Impact and Industry Trends
Table of Contents
1. Executive Summary 2. Introduction to Drug Delivery 2.1. Drug Delivery Technologies and Pharmaceutical Revenues 2.2. Drug Delivery Technologies and Wider Healthcare Market 3. Overview of Injectable Drug Delivery 3.1. Advantages and Disadvantages of Injectable Delivery 3.2. Types of Injectable Drug Delivery 4. Main Categories of Marketed Injectable Drug Delivery Systems 4.1. Sustained Release Injectable Systems 4.2. Advantages of Injectable Sustained-Release Formulations 4.3. Liposomal Systems 4.4. Advantages of Injectable Liposomal Formulations 4.5. Needleless Systems 4.6. Advantages of Injectable Needleless Formulations 5. Injectable Drug Delivery Market - Facts and Figures 5.1. Injectable Drug Delivery Market Overview 5.2. Key Therapeutic Areas for Injectable Drug Delivery 5.3. Acromegaly 5.4. Age-Related Macular Degeneration 5.5. Crohn’s Disease 5.6. Diabetes 5.7. Hepatitis C 5.8. Multiple Sclerosis 5.9. Neutropenia 5.10. Oncology 5.11. Pain 5.12. Psoriasis 5.13. Rheumatoid Arthritis 6. Drug Classes Appropriate for Injectable Drug Delivery 7. Main Players and Partnerships in the Injectable Drug Delivery Market 8. Key Company Involvement in the Field of Injectable Drug Delivery 8.1. Alkermes 8.2. ALZA 8.3. Aradigm 8.4. Bioject

8.5. Enzon 8.6. Ethypharm 8.7. MacroMed 8.8. Nektar Therapeutics 8.9. QLT 8.10. SkyePharma 9. Sales of Products Utilizing Injectable Drug Delivery Technology 10. Profiles of Key Products Using Injectable Drug Delivery Technology 10.1. Neulasta (Nektar/Amgen) 10.2. PEGASYS (Roche/Nektar) 10.3. PEG-Intron (Schering-Plough) 10.4. Risperdal Consta 10.5. Sandostatin (Novartis) 10.6. Vivitrol (Alkermes) 11. Recent Launches and Approvals in the Field of Injectable Drug Delivery 11.1. August 2006 11.2. July 2006 11.3. May 2006 11.4. April 2006 11.5. February 2006 11.6. January 2006 12. Current Research and Profiles of Key Pipeline Products in the Field of Injectable Drug Delivery 12.1. Cimzia (Nektar) 12.2. Mircera/CERA (Nektar) 12.3. Paliperidone Palmitate (Johnson & Johnson) 12.4. Intraject Sumatriptan (Zogenix) 13. Future of Injectable Drug Delivery Technology 13.1. Emerging Injectable Drug Delivery Technologies 13.2. Emerging Therapeutic Targets for Injectable Drug Delivery 13.3. Future Therapeutic Targets for Injectable Drug Delivery 13.4. New Technology and the Injectable Drug Delivery Market 13.5. New Threats to the Injectable Drug Delivery Market 13.6. New Healthcare Needs and the Injectable Drug Delivery 14. Outlook for Injectable Drug Delivery Technology List of Tables Table 2.1 Drivers of New Drug Delivery Technologies Table 2.2 Advantages of New Drug Delivery Technology Table 3.1 Types of Injectable Delivery Table 4.1 Key Companies in the Needleless Drug Technology Market Table 5.1 Leading MS Therapy Delivery Routes and Dosage Table 5.2 Key Biologics for the Treatment of Psoriasis Table 5.3 Administration Methods of Main RA Therapies

Table 7.1 Leading Injectable Drug Delivery Companies 2005, Key Products and Sales 2005 ($ mn) Table 7.2 Novartis’ Pipeline Major Drug Delivery Partners Table 8.1 Key Details of Main Companies in the Field of Injectable Drug Delivery Table 8.2 Alkermes’ Injectable Drug Delivery Portfolio, 2006 Table 8.3 Bioject’s Injectable Drug Delivery Portfolio, 2006 Table 8.4 Enzon’s Injectable Drug Delivery Portfolio, 2006 Table 8.5 Ethypharm’s Injectable Drug Delivery Portfolio, 2006 Table 8.6 MacroMed’s Injectable Drug Delivery Portfolio, 2006 Table 8.7 Nektar’s Injectable Drug Delivery Portfolio, 2006 Table 8.8 SkyePharma’s Injectable Drug Delivery Portfolio, 2006 Table 9.1 Key Injectable Drug Delivery Products, 2004-2005 ($ mn) Table 10.1 GH Suppression During Long-Term Treatment with Immediate Release Sandostatin Injection and Sandostatin LAR Depot Table 10.2 Comparison of Acromegaly Symptoms with Immediate Release Sandostatin Injection and Sandostatin LAR Depot as Reported by Patients Table 13.1 Key Injectable Drug Delivery R&D Pipeline Drugs, 2006 Table 13.2 Other Viral and Bacterial Infections to Which Injectable Technology is Applicable Table 13.3 Emerging Therapeutic Areas for Injectable Drug Delivery Table 13.4 DOR BioPharma Drug Delivery Portfolio, 2006 Table 14.1 Drivers and Restraints of Injectable Drug Delivery List of Graphs Graph 5.1 2005 Sales of Leading MS Therapies Graph 5.2 2005 Sales of Leading Psoriasis Biologics Graph 5.3 2005 Sales of Leading RA Therapies Graph 7.1 Leading Injectable Drug Delivery Companies, Combined Key Product Values 2005 ($ mn) Graph 7.2 Leading Companies Active in Injectable Drug Delivery Development, Number of Products Graph 9.1 Top Ten Products Utilizing Injectable Delivery, Global Sales 2005 ($ mn) List of Figures Figure 4.1 Patient Perception of Iject and Associated Pain Figure 8.1 Illustration of ALZAMER’s PLGA Solvent Control over Protein Release Figure 8.2 Advanced PEGylated Drug Molecules Figure 8.3 Four Stages of Photodynamic Therapy Figure 12.1 Illustration of NanoCrystal Dispersion’s Advantages Figure 13.1 Comparison of Morphine Delivery Technologies: Oral, Injectable and Transmucosal


				
DOCUMENT INFO
Shared By:
Stats:
views:93
posted:1/18/2010
language:English
pages:3
Description: Injectable Drug Delivery